X0609 4 2026-09-11 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001567160 Gano Kyle false 6027 EDGEWOOD BEND CT. SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer 0 Common Stock 2026-09-11 4 A 0 6275 0 A 157266 D Common Stock 2026-09-11 4 F 0 3386 156.22 D 153880 D Common Stock 2026-09-11 4 A 0 1842 0 A 155722 D Common Stock 2026-09-11 4 F 0 994 156.22 D 154728 D The Reporting Person was previously granted performance restricted stock units (PRSUs) that vest upon the achievement of certain performance metrics, the achievement of one of which was certified on September 11, 2026. Includes an aggregate of 176 shares purchased on February 27, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of PRSUs. No shares were sold. /s/ Darin Lippoldt, Attorney-in-Fact 2026-09-15